
Medirom Healthcare Receives Nasdaq Delisting Notice; Appeals Determination
Medirom Healthcare Technologies Inc. received a notice from Nasdaq indicating non-compliance with listing rules due to the delayed filing of its 2025 Annual Report. The company has requested a hearing to appeal the delisting determination and has filed the report. Separately, Medirom is also non-compliant with the minimum bid price requirement, with a deadline of April 5, 2027, to regain compliance. The company operates wellness salons and has expanded into HealthTech and smart tracker manufacturing.
Key Highlights
- Medirom Healthcare Technologies Inc. received a delisting notice from Nasdaq for failing to file its 2025 Annual Report on time.
- The company has requested a hearing before a Nasdaq Hearings Panel to appeal the delisting determination.
- Trading of Medirom's American Depositary Shares is subject to suspension and delisting from Nasdaq starting November 24, 2026, unless an appeal is successful.
- Medirom has also received a separate notice for non-compliance with the minimum bid price requirement, with a deadline of April 5, 2027, to regain compliance.
- The company filed its 2025 Annual Report on November 18, 2026, in support of its appeal.
Price Impact
More from MRM
MEDIROM Regains Nasdaq Periodic Filing Compliance; Bid Price Deficiency Remains
Medirom Receives Nasdaq Delisting Notice, Files Annual Report, Seeks Hearing
Medirom Healthcare Technologies Receives Nasdaq Bid Price Non-Compliance Notice